摘要
对天津市药品不良反应监测中心2005年收集的97份《药品不良反应/事件定期汇总表》的质量进行审核分析,提示药品生产企业在提高报表质量的同时,更应定期加强对其产品安全性的全面考察。
The quality of 97 ADR/ADE Periodic Safety Reports collected by Tianjin center for ADR monitoring in 2005 was analyzed. It is indicated that the pharmaceutical manufactories should strengthen evaluating the safety of their products periodically, as well as improving the quality of Periodic Safety Reports.
出处
《中国药物警戒》
2006年第4期202-204,共3页
Chinese Journal of Pharmacovigilance
关键词
天津市
药品生产企业
药品不良反应/事件
定期汇总表
分析
Tianjin
pharmaceutical manufactories
adverse drug reaction/event
periodic safety report
analyze
